Qube Research & Technologies (QRT)
UPB

Qube Research & Technologies (QRT)’s Upstream Bio Inc UPB Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio UPB Stock Details UPB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.57M Buy
+619,321
New +$11.1M 0.01% 1591

Other funds holding UPB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Qube Research & Technologies (QRT)'s UPB Position: Q1 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Upstream Bio Inc (UPB) in Q1 2026: 619,321 shares worth $5.57M. The stake represents 0.01% of the portfolio and ranks #1591 among its holdings.

140 funds tracked by Wall St. Rank hold UPB as of Q1 2026.

  • Qube Research & Technologies (QRT) held 619,321 shares of Upstream Bio Inc worth $5.57M as of Q1 2026.
  • Upstream Bio Inc was a new Qube Research & Technologies (QRT) position in Q1 2026.
  • Upstream Bio Inc made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #1591 holding.
  • 140 funds tracked by Wall St. Rank held Upstream Bio Inc as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.